Pharmacological tool compounds for the free fatty acid receptor 4 (FFA4/GPR120)

Handbook of Experimental Pharmacology

Volumn 236, Issue , 2017, Pages 33-56

  Hansen, Steffen V F ^a   Ulven, Trond ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Chemical probes; FFA4; GPR120; Tool compound

Indexed keywords

AH 7614; ANT 203; AZ 423; AZ 670; CPD 15I; CPD 2; CPD 39; CPD 8; CYTOKINE RECEPTOR AGONIST; CYTOKINE RECEPTOR ANTAGONIST; DC 260126; DOCOSAHEXAENOIC ACID; G PROTEIN COUPLED RECEPTOR 120; GLPG 0974; GSK 137647A; GW 1100; GW 9508; LINOLENIC ACID; LONG CHAIN FATTY ACID; TUG 1197; TUG 891; UNCLASSIFIED DRUG; 3-(4-((4-FLUORO-4'-METHYL-(1,1'-BIPHENYL)-2-YL)METHOXY)PHENYL)PROPANOIC ACID; BIPHENYL DERIVATIVE; FFAR1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GW9508; METHYLAMINE; O3FAR1 PROTEIN, HUMAN; PHENYLPROPIONIC ACID DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; DIET INDUCED OBESITY; DRUG METABOLISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; EC50; HUMAN; IC50; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; INFLAMMATION; INSULIN RESISTANCE; OBESITY; PHYSIOLOGY;

ANIMALS; BIPHENYL COMPOUNDS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METHYLAMINES; OBESITY; PHENYLPROPIONATES; PROPIONATES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85014127867     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/164_2016_60     Document Type: Chapter

References (88)

1. Anighoro A, Bajorath J, Rastelli G (2014) Polypharmacology: challenges and opportunities in drug discovery. J Med Chem 57:7874-7887
2. Arakawa K, Nishimura T, Sugimoto Y, Takahashi H, Shimamura T (2010) Preparation of heteroaryloxyphenyldihydrobenzisothiazoledioxide derivatives and analogs for use as GPR120 receptor modulators. Banyu Pharmaceutical, Tokyo. WO2010104195A1
3. Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J et al (2015) The promise and peril of chemical probes. Nat Chem Biol 11:536-541
4. Azevedo CM, Watterson KR, Wargent ET, Hansen SVF, Hudson BD, Kepczynska M et al (2016) A non-acidic free fatty acid receptor 4 agonists with antidiabetic activity. J Med Chem 59:8868-8878. doi:10.1021/acs.jmedchem.6b00685
5. Baell JB, Holloway GA (2010) New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719-2740
6. Bang-Andersen B, Ruhland T, Jorgensen M, Smith G, Frederiksen K, Jensen KG et al (2011) Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem 54:3206-3221
7. Boettcher M, McManus MT (2015) Choosing the right tool for the job: RNAi, TALEN, or CRISPR. Mol Cell 58:575-585
8. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR et al (2006) Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 148:619-628
9. Bunnage ME, Chekler EL, Jones LH (2013) Target validation using chemical probes. Nat Chem Biol 9:195-199
10. Butcher AJ, Hudson BD, Shimpukade B, Alvarez-Curto E, Prihandoko R, Ulven T et al (2014) Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4. J Biol Chem 289:18451-18465
11. Calder PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142:592s-599s
12. Chelliah M, Chu HD, Cox JM, Debenham JS, Eagen K, Lan P et al (2014) Preparation of substituted spiropiperidinyl compounds useful as GPR120 agonists. Merck Sharp & Dohme, Kenilworth, NJ. WO2014059232A2
13. Christiansen E, Urban C, Grundmann M, Due-Hansen ME, Hagesaether E, Schmidt J et al (2011) Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. J Med Chem 54:6691-6703
14. Christiansen E, Due-Hansen ME, Urban C, Grundmann M, Schroder R, Hudson BD et al (2012) Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. J Med Chem 55:6624-6628
15. Christiansen E, Due-Hansen ME, Urban C, Grundmann M, Schmidt J, Hansen SVF et al (2013) Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. J Med Chem 56:982-992
16. Christiansen E, Watterson KR, Stocker CJ, Sokol E, Jenkins L, Simon K et al (2015) Activity of dietary fatty acids on FFA1 and FFA4 and characterization of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. Br J Nutr 113:1677-1688
17. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, Souza CT et al (2012) Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS One 7, e30571
18. Cornish J, MacGibbon A, Lin JM, Watson M, Callon KE, Tong PC et al (2008) Modulation of osteoclastogenesis by fatty acids. Endocrinology 149:5688-5695
19. Davenport AP, Alexander SPH, Sharman JL, Pawson AJ, Benson HE, Monaghan AE et al (2013) International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev 65:967-986
20. Defossa E, Wagner M (2014) Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus. Bioorg Med Chem Lett 24:2991-3000
21. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107
22. Egerod KL, Engelstoft MS, Lund ML, Grunddal KV, Zhao M, Barir-Jensen D et al (2015) Transcriptional and functional characterization of the G protein-coupled receptor repertoire of gastric somatostatin cells. Endocrinology 156:3909-3923
23. Engelstoft MS, Park WM, Sakata I, Kristensen LV, Husted AS, Osborne-Lawrence S et al (2013) Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. Mol Metab 2:376-392
24. Formicola R, Pevarello P, Kuhn C, Liberati C, Piscitelli F, Sodano M (2015) FFA4/GPR120 agonists: a survey of the recent patent literature. Pharm Pat Anal 4:443-451
25. Frye SV (2010) The art of the chemical probe. Nat Chem Biol 6:159-161
26. Fukushima K, Yamasaki E, Ishii S, Tomimatsu A, Takahashi K, Hirane M et al (2015) Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells. Biochem Biophys Res Commun 465:512-515
27. Gao B, Huang Q, Jie Q, Lu W-G, Wang L, Li X-J et al (2015) GPR120: a bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs. Sci Rep 5:14080
28. Garrel G, Simon V, Denoyelle C, Cruciani-Guglielmacci C, Migrenne S, Counis R et al (2011) Unsaturated fatty acids stimulate LH secretion via novel PKCepsilon and -theta in gonadotrope cells and inhibit GnRH-induced LH release. Endocrinology 152:3905-3916
29. Gong Z, Yoshimura M, Aizawa S, Kurotani R, Zigman JM, Sakai T et al (2014) G protein-coupled receptor 120 signaling regulates ghrelin secretion in vivo and in vitro. Am J Physiol Endocrinol Metab 306:E28-E35
30. Gozal D, Qiao Z, Almendros I, Zheng J, Khalyfa A, Shimpukade B et al (2016) Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice. Int J Obes 40:1143-1149
31. Hakim F, Kheirandish-Gozal L, Gozal D (2015a) Obesity and altered sleep: a pathway to metabolic derangements in children? Semin Pediatr Neurol 22:77-85
32. Hakim F, Wang Y, Carreras A, Hirotsu C, Zhang J, Peris E et al (2015b) Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice. Sleep 38:31-40
33. Halder S, Kumar S, Sharma R (2013) The therapeutic potential of GPR120: a patent review. Expert Opin Ther Pat 23:1581-1590
34. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M et al (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94
35. Hostetler HA, Kier AB, Schroeder F (2006) Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor α (PPARα). Biochemistry 45:7669-7681
36. Hudson BD, Murdoch H, Milligan G (2013a) Minireview: the effects of species ortholog and SNP variation on receptors for free fatty acids. Mol Endocrinol 27:1177-1187
37. Hudson BD, Shimpukade B, Mackenzie AE, Butcher AJ, Pediani JD, Christiansen E et al (2013b) The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol 84:710-725
38. Hudson BD, Shimpukade B, Milligan G, Ulven T (2014) The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120). J Biol Chem 289:20345-20358
39. Humphries PS, Benbow JW, Bonin PD, Boyer D, Doran SD, Frisbie RK et al (2009) Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists. Bioorg Med Chem Lett 19:2400-2403
40. Ishii S, Hirane M, Kato S, Fukushima N, Tsujiuchi T (2015a) Opposite effects of GPR120 and GPR40 on cell motile activity induced by ethionine in liver epithelial cells. Biochem Biophys Res Commun 456:135-138
41. Ishii S, Hirane M, Kitamura Y, Mori S, Fukushima N, Honoki K et al (2015b) Role of GPR120 in cell motile activity induced by 12-O-tetradecanoylphorbol-13-acetate in liver epithelial WB-F344 cells. Mol Cell Biochem 400:145-151
42. Kim HJ, Yoon HJ, Kim BK, Kang WY, Seong SJ, Lim MS et al (2015) G protein-coupled receptor 120 signaling negatively regulates osteoclast differentiation, survival, and function. J Cell Physiol 231:844-851
43. Kita T, Kadochi Y, Takahashi K, Fukushima K, Yamasaki E, Uemoto T et al (2016) Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells. Exp Cell Res 342:193-199
44. Kodadek T (2010) Rethinking screening. Nat Chem Biol 6:162-165
45. Konno Y, Ueki S, Takeda M, Kobayashi Y, Tamaki M, Moritoki Y et al (2015) Functional analysis of free fatty acid receptor GPR120 in human eosinophils: implications in metabolic homeostasis. PLoS One 10, e0120386
46. Kristinsson H, Smith DM, Bergsten P, Sargsyan E (2013) FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion. Endocrinology 154:4078-4088
47. Lengqvist J, Mata De Urquiza A, Bergman AC, Willson TM, Sjovall J, Perlmann T et al (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 3:692-703
48. Li X, Yu Y, Funk CD (2013a) Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J 27:4987-4997
49. Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J et al (2013b) Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem 288:9583-9592
50. Liu Y, Chen LY, Sokolowska M, Eberlein M, Alsaaty S, Martinez-Anton A et al (2014) The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A(2) via GPR120 receptor to produce prostaglandin E(2) and plays an anti-inflammatory role in macrophages. Immunology 143:81-95
51. Liu Z, Hopkins MM, Zhang Z, Quisenberry CB, Fix LC, Galvan BM et al (2015) Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther 352:380-394
52. Ma J, Novack A, Nashashibi I, Pham P, Rabbat CJ, Song J et al (2010) [(Heterocyclylmethoxy) aryl]alkanoic acid derivatives as GPR120 receptor agonists and preparation and uses thereof. Metabolex, Hayward, CA. WO2010048207A2
53. Martin C, Passilly-Degrace P, Chevrot M, Ancel D, Sparks SM, Drucker DJ et al (2012) Lipid- mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res 53:2256-2265
54. Milligan G, Alvarez-Curto E, Watterson KR, Ulven T, Hudson BD (2015) Characterising pharmacological ligands to study the long chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. Br J Pharmacol 172:3254-3265
55. Milligan G, Shimpukade B, Ulven T, Hudson BD (2016) Complex pharmacology of free fatty acid receptors. Chem Rev. doi:10.1021/acs.chemrev.6b00056
56. Mizuta K, Zhang Y, Mizuta F, Hoshijima H, Shiga T, Masaki E et al (2015) Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 309:L970-L982
57. Moniri NH (2016) Free-fatty acid receptor-4 (GPR120): cellular and molecular function and its role in metabolic disorders. Biochem Pharmacol 110-111:1-15
58. Offermanns S (2014) Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annu Rev Pharmacol Toxicol 54:407-434
59. Oh da Y, Olefsky JM (2016) G protein-coupled receptors as targets for anti-diabetic therapeutics. Nat Rev Drug Discov 15:161-172
60. Oh da Y, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR et al (2014) A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 20:942-947
61. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan WQ et al (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687-698
62. Peters JU (2013) Polypharmacology - foe or friend? J Med Chem 56:8955-8971
63. Pizzonero M, Dupont S, Babel M, Beaumont S, Bienvenu N, Blanque R et al (2014) Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic. J Med Chem 57:10044-10057
64. Pouliot M, Jeanmart S (2016) Pan Assay Interference Compounds (PAINS) and other promiscuous compounds in antifungal research. J Med Chem 59:497-503
65. Prihandoko R, Alvarez-Curto E, Hudson BD, Butcher AJ, Ulven T, Miller AM et al (2016) Distinct phosphorylation clusters determine the signaling outcome of free fatty acid receptor 4/G protein-coupled receptor 120. Mol Pharmacol 89:505-520
66. Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, Graf R et al (2014) GPR120 on Kupffer cells mediates hepatoprotective effects of omega3-fatty acids. J Hepatol 60:625-632
67. Reddy AS, Zhang S (2013) Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 6:41-47
68. Sergeev E, Hojgaard Hansen A, Pandey SK, Mackenzie AE, Hudson BD, Ulven T et al (2015) Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands. J Biol Chem 291:303-317
69. Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92-101
70. Shi DF, Song J, Ma J, Novack A, Pham P, Nashashibi I et al (2010) Preparation of benzofuranyl substituted phenylalkylcarboxylic acids as Gpr120 receptor agonists. Metabolex, Hayward, CA. WO2010080537A1
71. Shimpukade B, Hudson BD, Hovgaard CK, Milligan G, Ulven T (2012) Discovery of a potent and selective GPR120 agonist. J Med Chem 55:4511-4515
72. Song T, Peng J, Ren J, Wei HK, Peng J (2015) Cloning and characterization of spliced variants of the porcine G protein coupled receptor 120. Biomed Res Int 2015:813816
73. Song T, Zhou Y, Peng J, Tao YX, Yang Y, Xu T et al (2016) GPR120 promotes adipogenesis through intracellular calcium and extracellular signal-regulated kinase 1/2 signal pathway. Mol Cell Endocrinol 434:1-13
74. Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C et al (2014) Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). Bioorg Med Chem Lett 24:3100-3103
75. Stone VM, Dhayal S, Brocklehurst KJ, Lenaghan C, Sorhede Winzell M, Hammar M et al (2014) GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia 57:1182-1191
76. Sun P, Wang T, Zhou Y, Liu H, Jiang H, Zhu W et al (2013) DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic beta-Cells dysfunction in db/db mice. PLoS One 8, e66744
77. Talukdar S, Olefsky JM, Osborn O (2011) Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 32:543-550
78. Tikhonova IG, Sum CS, Neumann S, Engel S, Raaka BM, Costanzi S et al (2008) Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. J Med Chem 51:625-633
79. Tsukahara T, Watanabe K, Watanabe T, Yamagami H, Sogawa M, Tanigawa T et al (2015) Tumor necrosis factor alpha decreases glucagon-like peptide-2 expression by up-regulating G-protein- coupled receptor 120 in Crohn disease. Am J Pathol 185:185-196
80. Ulven T, Christiansen E (2015) Dietary influences on regulation of the long-chain fatty acid receptor FFA4/GPR120. Annu Rev Nutr 35:239-263
81. 2 receptors DP and CRTH2 for treatment of inflammation. Curr Top Med Chem 6:1427-1444
82. Waring MJ, Baker DJ, Bennett SNL, Dossetter AG, Fenwick M, Garcia R et al (2015) Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40. Med Chem Commun 6:1024-1029
83. Watson SJ, Brown AJ, Holliday ND (2012) Differential signaling by splice variants of the human free fatty acid receptor GPR120. Mol Pharmacol 81:631-642
84. Wauquier F, Philippe C, Leotoing L, Mercier S, Davicco MJ, Lebecque P et al (2013) The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation. J Biol Chem 288:6542-6551
85. Wellhauser L, Belsham DD (2014) Activation of the omega-3 fatty acid receptor GPR120 mediates anti-inflammatory actions in immortalized hypothalamic neurons. J Neuroinflammation 11:60
86. Workman P, Collins I (2010) Probing the probes: fitness factors for small molecule tools. Chem Biol 17:561-577
87. Wu Q, Wang H, Zhao X, Shi Y, Jin M, Wan B et al (2013) Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 32:5541-5550
88. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C et al (2013) Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38:1154-1163